Sign in

Private company

Akili, Inc.

In its 2024 annual report the company says: “Akili is a leading digital medicine company, pioneering the development of cognitive treatments through game-changing technologies. Our approach of developing and commercializing technologies designed to directly target the physiology of the brain has established a new category of medicine—medicine that is validated through clinical trials like a drug or medical device, but experienced like entertainment.”4 It is headquartered in Boston, Massachusetts.1

Last updated Oct 21, 2026.

Overview

  • IndustrySurgical & Medical Instruments & Apparatus1
  • HeadquartersBoston, Massachusetts1
  • Business address71 Commercial Street, Mailbox 312, Boston, Ma 021092
  • Filer category, Emerging growth company2

See how the biggest companies compare on our leaderboards

Akili is a leading digital medicine company, pioneering the development of cognitive treatments through game-changing technologies. Our approach of developing and commercializing technologies designed to directly target the physiology of the brain has established a new category of medicine—medicine that is validated through clinical trials like a drug or medical device, but experienced like entertainment. We began as a prescription digital medicine company; however, in September 2023 we announced a strategic plan to transition from a prescription to a non-prescription business model, including our plans to pursue regulatory authorization for over-the-counter labeling of our products.4 From its latest annual report

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Key numbers, fiscal 2023

51.2%Gross margin5
-3843.0%Operating margin5
-3545.5%Net margin5
419.5%Revenue growth, 20235
-101.6%Return on equity5
-$57.9MFree cash flow5

Where the money goes

Where each dollar of revenue went, fiscal 2023

  • Cost of revenue1¢$819.0K
  • Research and development29¢$19.9M
  • Selling, general and admin66¢$45.4M
  • Interest3¢$2.4M
  • Income tax0¢$53.0K

Out of $1.7M in revenue.5 The company lost money this year.

Financial statements

Revenue65$1.7M in 2023+212% since 2021
0$500.0K$1.0M$1.5M$2.0M2021: $538.0K$538.0K20212022: $323.0K$323.0K2022−40%2023: $1.7M$1.7M2023+420%
Gross profit65$859.0K in 2023+369% since 2021
-$250.0K0$250.0K$500.0K$750.0K$1.0M2021: $183.0K$183.0K20212022: -$118.0K-$118.0K20222023: $859.0K$859.0K2023
Operating income65-$64.5M in 2023+6% since 2021
-$100.0M-$75.0M-$50.0M-$25.0M02021: -$60.7M-$60.7M20212022: -$90.7M-$90.7M2022+49%2023: -$64.5M-$64.5M2023−29%
Net income65-$59.5M in 2023−3% since 2021
-$80.0M-$60.0M-$40.0M-$20.0M02021: -$61.3M-$61.3M20212022: -$8.0M-$8.0M2022−87%2023: -$59.5M-$59.5M2023+647%
Fiscal year2020202120222023
Revenue$538.0K6$323.0K5$1.7M5
Cost of revenue$355.0K6$441.0K5$819.0K5
Gross profit$183.0K6-$118.0K5$859.0K5
Research and development$18.2M6$28.9M5$19.9M5
Selling, general and admin$42.7M6$61.7M5$45.4M5
Operating expenses$60.9M6$90.6M5$65.3M5
Operating income-$60.7M6-$90.7M5-$64.5M5
Interest$465.0K6$1.5M5$2.4M5
Income before tax-$61.3M6-$7.9M5-$59.4M5
Income tax$19.0K5$53.0K5
Net income-$61.3M6-$8.0M5-$59.5M5
Earnings per share-$91.886-$0.645-$0.765
Earnings per share (diluted)-$91.886-$0.645-$0.765
Shares (weighted, basic)1.4M shares629.9M shares578.2M shares5
Shares (weighted, diluted)1.4M shares629.9M shares578.2M shares5

Compare Akili, Inc. with another company

Corporate structure

Akili, Inc. sits at the top of its group. 3 entities, 1 country on record. Switch between the flow chart and the network, and select any entity to see its details.

Major holders of Akili, Inc.

  • Akili, Inc. Boston, Massachusetts
    • Akili Interactive Labs, Inc. Subsidiary · Delaware, United States
    • Akili Securities Corporation (a wholly owned subsidiary of Akili Interactive Labs, Inc.) Subsidiary · Delaware, United States

Built from subsidiaries listed in Exhibit 21 of annual reports filed with the SEC; major holders from Schedules 13D and 13G. Each entity in the chart links to its source.

What it owns

What Akili, Inc. reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.

Property and equipment

ItemLatestA year beforeChange
Property and equipment, before depreciation$1.9M5 Dec 31, 2023$2.1M5 Dec 31, 2022−12.2%
Accumulated depreciation$1.2M5 Dec 31, 2023$1.2M5 Dec 31, 2022−1.6%
Property and equipment, net$680.0K5 Dec 31, 2023$919.0K5 Dec 31, 2022−26.0%
Operating-lease assets (leased space)$1.6M5 Dec 31, 2023$2.6M5 Dec 31, 2022−39.3%

Investments

ItemLatestA year beforeChange
Cash and cash equivalents$75.2M5 Dec 31, 2023$54.1M5 Dec 31, 2022+38.9%
Marketable securities, current$82.0M5 Dec 31, 2022

Leadership

Who has led Akili, Inc., and when. Pick a name to see everywhere that person has worked.

Chief executive

  1. Walter Edward Martucci Ii.2022–2023
  2. Matthew Franklin2023–2024

President

  1. Matthew Franklin2023–2024

Chief financial officer

  1. James Ryans2021
  2. Santosh Shanbhag2022–2023

Chief operating officer

  1. Matthew Franklin2023
2025
Board members and other officers (19)

Subsidiaries and ownership

Subsidiaries (Exhibit 21)

  • Akili Interactive Labs, Inc. Delaware3
  • Akili Securities Corporation (a wholly owned subsidiary of Akili Interactive Labs, Inc.) Delaware3

The subsidiaries the company lists in Exhibit 21 of its annual report, as filed.

Former names

  • Social Capital Suvretta Holdings Corp. IApr 21, 2021 to Aug 12, 20222

Timeline

  1. Jul 2, 20248-K Completed an acquisition or sale; Listing notice or transfer; Change to shareholders' rights31
  2. Jun 18, 20248-K Other events32
  3. May 29, 20248-K Entered a material agreement; Regulation FD disclosure33
  4. May 14, 20248-K Results of operations34
  5. Apr 30, 20248-K Entered a material agreement; Exit or restructuring costs; Other events35
  6. Apr 23, 20248-K Listing notice or transfer; Shareholder vote36
  7. Feb 29, 20248-K Results of operations37
  8. Feb 26, 20248-K Other events38
  9. Feb 21, 20248-K Executive or director change; Regulation FD disclosure39
  10. Jan 5, 20248-K Executive or director change40
  11. Dec 20, 20238-K Listing notice or transfer; Executive or director change41
  12. Dec 18, 20238-K Other events42
  13. Oct 13, 2023New chief executive Matthew Franklin becomes CEO10
  14. Aug 19, 2022New chief executive Walter Edward Martucci Ii. becomes CEO11

Calendar

When it reported results

  1. May 14, 2024Reported quarterly or annual results34
  2. Feb 29, 2024Reported quarterly or annual results37
  3. Nov 9, 2023Reported quarterly or annual results43
  4. Aug 10, 2023Reported quarterly or annual results44
  5. May 12, 2023Reported quarterly or annual results45
  6. May 11, 2023Reported quarterly or annual results46
  7. Mar 7, 2023Reported quarterly or annual results47
  8. Nov 10, 2022Reported quarterly or annual results48

Upcoming dates from Nasdaq's calendar; past results from the company's 8-K filings (Item 2.02). The full markets calendar

Filings

241 filings to the SEC since October 2021: 3 annual reports, 8 quarterly reports, 39 major events, 72 insider forms, 27 large holders, 92 other. The latest 20:

  1. Nov 13, 2024SC 13G/A EDGAR
  2. Aug 9, 2024SC 13G/A EDGAR
  3. Aug 5, 2024SC 13G/A EDGAR
  4. Jul 12, 202415-12G EDGAR
  5. Jul 9, 2024EFFECT EDGAR
  6. Jul 9, 2024SC 13D/A EDGAR
  7. Jul 8, 20244 EDGAR
  8. Jul 5, 2024SC 13D/A SCHEDULE 13D, AMENDMENT NO. 3 EDGAR
  9. Jul 5, 2024SC 13G/A EDGAR
  10. Jul 5, 20244 EDGAR
  11. Jul 5, 20244 EDGAR
  12. Jul 2, 20244 PRIMARY DOCUMENT EDGAR
  13. Jul 2, 20244 PRIMARY DOCUMENT EDGAR
  14. Jul 2, 20244 PRIMARY DOCUMENT EDGAR
  15. Jul 2, 20244 PRIMARY DOCUMENT EDGAR
  16. Jul 2, 20244 PRIMARY DOCUMENT EDGAR
  17. Jul 2, 2024S-8 POS EDGAR
  18. Jul 2, 2024S-8 POS EDGAR
  19. Jul 2, 2024POS AM EDGAR
  20. Jul 2, 20248-K EDGAR

The 241 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Insider trades

4 open-market trades by officers, directors and large owners since October 2021: 0 buys and 4 sales. Grants, option exercises and gifts are left out.

DateWhoTradeSharesPriceValueFiling
Sep 11, 2023Studer JacquelineChief Legal OfficerSale1,130$1.05$1.2KForm 4
Sep 11, 2023Martucci Walter Edward IIDirectorSale2,353$1.05$2.5KForm 4
Sep 11, 2023Franklin MatthewPresident & CEOSale1,728$1.05$1.8KForm 4
Sep 11, 2023Shanbhag SantoshChief Financial OfficerSale830$1.05$872Form 4

From Forms 4 filed with the SEC.

Major holders

Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.

SEC filer profile

How Akili, Inc. is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.

  • Name on EDGARAkili, Inc.1
  • CIK0001850266
  • Employer ID (EIN)92-36547721
  • Filer status<br>emerging growth company1
  • Fiscal year endsDecember 311
  • Industry code (SIC)3841 Surgical & Medical Instruments & Apparatus1
  • SEC reviewing officeOffice of Industrial Applications and Services, Division of Corporation Finance1
  • Business address71 Commercial Street, Mailbox 312, Boston, MA 021091
  • Phone617-456-05971
  • Shares outstanding78,509,823 as of Feb 21, 20245
  • Public float$67.0M as of Jun 30, 20235
  • On EDGAR sinceApr 21, 20211
  • Filings268 in all: 4 (49), 8-K (38), 3 (22), 425 (19), 424B3 (15), CORRESP (13), SC 13G/A (12), SC 13G (10)1
    All 42 form types

    10-Q (9), UPLOAD (9), 3/A (8), EFFECT (6), S-4/A (5), SC 13D/A (5), 8-K/A (4), POS AM (4), S-1/A (4), 10-K (3), ARS (2), DEF 14A (2), DEFA14A (2), S-1 (2), S-8 (2), S-8 POS (2), SC 13D (2), SC14D9C (2), SEC STAFF LETTER (2), 15-12G (1), 25-NSE (1), 424B4 (1), 8-A12B (1), CERT (1), DEFM14A (1), DRS (1), PRE 14A (1), S-1MEF (1), S-4 (1), SC 14D9 (1), SC 14D9/A (1), SC TO-C (1), SC TO-T (1), SC TO-T/A (1)

  • Latest filingsAnnual report (10-K) Feb 29, 2024
    Quarterly report (10-Q) May 14, 2024
    Proxy statement (DEF 14A) Mar 6, 2024
    Latest 8-K (8-K) Jul 2, 2024

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20
  21. 21
  22. 22
  23. 23
  24. 24
  25. 25
  26. 26
  27. 27
  28. 28
  29. 29
  30. 30
  31. 31
  32. 32
    SEC EDGAROther events
  33. 33
  34. 34
  35. 35
  36. 36
  37. 37
  38. 38
    SEC EDGAROther events
  39. 39
  40. 40
  41. 41
  42. 42
    SEC EDGAROther events
  43. 43
  44. 44
  45. 45
  46. 46
  47. 47
  48. 48
  49. 49
  50. 50
  51. 51
  52. 52
  53. 53
  54. 54
  55. 55
  56. 56
  57. 57
  58. 58
  59. 59
  60. 60
  61. 61